Increased osteoclast activity is associated with aggressiveness of osteosarcoma

Sofia Avnet, Alessandra Longhi, Manuela Salerno, Jussi M. Halleen, Francesca Perut, Donatella Granchi, Stefano Ferrari, Franco Bertoni, Armando Giunti, Nicola Baldini

Research output: Contribution to journalArticle

Abstract

Osteosarcoma (OS) is a highly malignant primary skeletal tumor with a striking tendency to rapidly destroy the surrounding bone and metastasize, since metastases are frequently present at clinical onset. The basis for the aggressiveness of this tumor is largely unknown. However, recent studies in in vivo models indicate that the anti-osteolytic drugs, bisphosphonates, can inhibit the tumor local expansion and the formation of metastases. We further investigated the association between the presence of active osteoclasts and the aggressiveness of OS. We evaluated the presence of osteoclasts and the mRNA of different osteoclast-related genes in tumor biopsies from 16 OS patients and in three OS cell lines and the serum levels of bone resorption markers in the same series and in 28 other patients. Tumor-associated osteoclasts were found in 63 and 75% of cases by histological and mRNA analysis. Among different serum markers, only MMP-9 was significantly higher in OS cases (p=0.0001), whereas TRACP 5b was significantly higher in metastatic patients compared to nonmetastatic patients (p=0.0509). Serum TRACP 5b was significantly correlated to serum NTX (p

Original languageEnglish
Pages (from-to)1231-1238
Number of pages8
JournalInternational Journal of Oncology
Volume33
Issue number6
DOIs
Publication statusPublished - 2008

Fingerprint

Osteoclasts
Osteosarcoma
Neoplasms
Serum
Neoplasm Metastasis
Messenger RNA
Diphosphonates
Bone Resorption
Matrix Metalloproteinases
Biomarkers
Biopsy
Bone and Bones
Cell Line
Pharmaceutical Preparations
Genes

Keywords

  • Bone turnover markers
  • Metastases
  • Osteoclast
  • Osteosarcoma
  • Tumor aggressiveness

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Increased osteoclast activity is associated with aggressiveness of osteosarcoma. / Avnet, Sofia; Longhi, Alessandra; Salerno, Manuela; Halleen, Jussi M.; Perut, Francesca; Granchi, Donatella; Ferrari, Stefano; Bertoni, Franco; Giunti, Armando; Baldini, Nicola.

In: International Journal of Oncology, Vol. 33, No. 6, 2008, p. 1231-1238.

Research output: Contribution to journalArticle

Avnet, Sofia ; Longhi, Alessandra ; Salerno, Manuela ; Halleen, Jussi M. ; Perut, Francesca ; Granchi, Donatella ; Ferrari, Stefano ; Bertoni, Franco ; Giunti, Armando ; Baldini, Nicola. / Increased osteoclast activity is associated with aggressiveness of osteosarcoma. In: International Journal of Oncology. 2008 ; Vol. 33, No. 6. pp. 1231-1238.
@article{1203b46f21ca416393009bd2ce18d8f5,
title = "Increased osteoclast activity is associated with aggressiveness of osteosarcoma",
abstract = "Osteosarcoma (OS) is a highly malignant primary skeletal tumor with a striking tendency to rapidly destroy the surrounding bone and metastasize, since metastases are frequently present at clinical onset. The basis for the aggressiveness of this tumor is largely unknown. However, recent studies in in vivo models indicate that the anti-osteolytic drugs, bisphosphonates, can inhibit the tumor local expansion and the formation of metastases. We further investigated the association between the presence of active osteoclasts and the aggressiveness of OS. We evaluated the presence of osteoclasts and the mRNA of different osteoclast-related genes in tumor biopsies from 16 OS patients and in three OS cell lines and the serum levels of bone resorption markers in the same series and in 28 other patients. Tumor-associated osteoclasts were found in 63 and 75{\%} of cases by histological and mRNA analysis. Among different serum markers, only MMP-9 was significantly higher in OS cases (p=0.0001), whereas TRACP 5b was significantly higher in metastatic patients compared to nonmetastatic patients (p=0.0509). Serum TRACP 5b was significantly correlated to serum NTX (p",
keywords = "Bone turnover markers, Metastases, Osteoclast, Osteosarcoma, Tumor aggressiveness",
author = "Sofia Avnet and Alessandra Longhi and Manuela Salerno and Halleen, {Jussi M.} and Francesca Perut and Donatella Granchi and Stefano Ferrari and Franco Bertoni and Armando Giunti and Nicola Baldini",
year = "2008",
doi = "10.3892/ijo_00000113",
language = "English",
volume = "33",
pages = "1231--1238",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Increased osteoclast activity is associated with aggressiveness of osteosarcoma

AU - Avnet, Sofia

AU - Longhi, Alessandra

AU - Salerno, Manuela

AU - Halleen, Jussi M.

AU - Perut, Francesca

AU - Granchi, Donatella

AU - Ferrari, Stefano

AU - Bertoni, Franco

AU - Giunti, Armando

AU - Baldini, Nicola

PY - 2008

Y1 - 2008

N2 - Osteosarcoma (OS) is a highly malignant primary skeletal tumor with a striking tendency to rapidly destroy the surrounding bone and metastasize, since metastases are frequently present at clinical onset. The basis for the aggressiveness of this tumor is largely unknown. However, recent studies in in vivo models indicate that the anti-osteolytic drugs, bisphosphonates, can inhibit the tumor local expansion and the formation of metastases. We further investigated the association between the presence of active osteoclasts and the aggressiveness of OS. We evaluated the presence of osteoclasts and the mRNA of different osteoclast-related genes in tumor biopsies from 16 OS patients and in three OS cell lines and the serum levels of bone resorption markers in the same series and in 28 other patients. Tumor-associated osteoclasts were found in 63 and 75% of cases by histological and mRNA analysis. Among different serum markers, only MMP-9 was significantly higher in OS cases (p=0.0001), whereas TRACP 5b was significantly higher in metastatic patients compared to nonmetastatic patients (p=0.0509). Serum TRACP 5b was significantly correlated to serum NTX (p

AB - Osteosarcoma (OS) is a highly malignant primary skeletal tumor with a striking tendency to rapidly destroy the surrounding bone and metastasize, since metastases are frequently present at clinical onset. The basis for the aggressiveness of this tumor is largely unknown. However, recent studies in in vivo models indicate that the anti-osteolytic drugs, bisphosphonates, can inhibit the tumor local expansion and the formation of metastases. We further investigated the association between the presence of active osteoclasts and the aggressiveness of OS. We evaluated the presence of osteoclasts and the mRNA of different osteoclast-related genes in tumor biopsies from 16 OS patients and in three OS cell lines and the serum levels of bone resorption markers in the same series and in 28 other patients. Tumor-associated osteoclasts were found in 63 and 75% of cases by histological and mRNA analysis. Among different serum markers, only MMP-9 was significantly higher in OS cases (p=0.0001), whereas TRACP 5b was significantly higher in metastatic patients compared to nonmetastatic patients (p=0.0509). Serum TRACP 5b was significantly correlated to serum NTX (p

KW - Bone turnover markers

KW - Metastases

KW - Osteoclast

KW - Osteosarcoma

KW - Tumor aggressiveness

UR - http://www.scopus.com/inward/record.url?scp=59049105619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59049105619&partnerID=8YFLogxK

U2 - 10.3892/ijo_00000113

DO - 10.3892/ijo_00000113

M3 - Article

C2 - 19020756

AN - SCOPUS:59049105619

VL - 33

SP - 1231

EP - 1238

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 6

ER -